Skip to main content
. 2021 May 18;108(6):691–701. doi: 10.1093/bjs/znaa195

Table 3.

Histopathological data

No. of patients* (n = 650)
Tumour size (mm) (n = 580) 13 (7–25)
No. of lymph nodes resected (n = 490) 10 (4–25)
No. of tumour‐positive lymph nodes (n = 531) 0 (0–3)
Lymph node ratio (n = 455) 0 (0–0·23)
T category
 T1a 213 (32·8)
 T1b 186 (28·6)
 T2 111 (17·1)
 T3 76 (11·7)
 T4a 29 (4·5)
 T4b 3 (0·5)
 Tx 3 (0·5)
 Unknown 29 (4·5)
N category
 N0 283 (43·5)
 N1a 106 (16·3)
 N1b 130 (20·0)
 Nx 88 (13·5)
 Unknown 43 (6·6)
M category
 M0 359 (55·2)
 M1 37 (5·7)
 Mx 162 (24·9)
 Unknown 92 (14·2)
Tumour stage
 I 289 (44·5)
 II 81 (12·5)
 III 97 (14·9)
 IVA 108 (16·6)
 IVB 1 (0·2)
 IVC 37 (5·7)
 Unknown 37 (5·7)
*

With percentages in parentheses unless indicated otherwise;

values are median (i.q.r.).